v3.25.1
Earnings (Loss) Per Share - Schedule of EPS (Details) - USD ($)
$ / shares in Units, $ in Millions
3 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Numerator for EPS - continuing operations    
Net loss from continuing operations $ (158.2) $ (28.4)
Less: Income from continuing operations attributed to non-controlling interests 14.2 7.4
Numerator for basic and diluted EPS from continuing operations attributable to Delek (172.4) (35.8)
Numerator for EPS - discontinued operations    
(Loss) income from discontinued operations, including gain on sale of discontinued operations (0.4) 3.6
Less: Income tax (benefit) expense (0.1) 0.4
(Loss) income from discontinued operations, net of tax $ (0.3) $ 3.2
Denominator:    
Weighted average common shares outstanding (denominator for basic EPS) (in shares) 62,115,776 64,021,988
Dilutive effect of stock-based awards (in shares) 0 0
Weighted average common shares outstanding, assuming dilution (denominator for diluted EPS) (in shares) 62,115,776 64,021,988
Basic loss per share:    
Loss from continuing operations (in dollars per share) $ (2.78) $ (0.56)
Income from discontinued operations (in dollars per share) 0 0.05
Total basic loss per share (in dollars per share) (2.78) (0.51)
Diluted loss per share:    
Loss from continuing operations (in dollars per share) (2.78) (0.56)
Income from discontinued operations (in dollars per share) 0 0.05
Total diluted loss per share (in dollars per share) $ (2.78) $ (0.51)
Antidilutive stock-based compensation (because average share price is less than exercise price)    
Diluted loss per share:    
Antidilutive securities excluded from computation of earnings per share (in shares) 2,823,263 829,292
Antidilutive due to loss    
Diluted loss per share:    
Antidilutive securities excluded from computation of earnings per share (in shares) 214,789 550,254
Total antidilutive stock-based compensation    
Diluted loss per share:    
Antidilutive securities excluded from computation of earnings per share (in shares) 3,038,052 1,379,546